Ignite Creation Date:
2024-05-06 @ 3:59 PM
Last Modification Date:
2024-10-26 @ 2:01 PM
Study NCT ID:
NCT04838106
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-07-18
First Post:
2021-04-07
Brief Title:
Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales
Sponsor:
University of Oxford
Organization:
University of Oxford
Study Overview
Official Title:
Outcomes of Patients Who Survived Treatment on an Intensive Care Unit for COVID-19 in England and Wales a Comparative Retrospective Cohort Study OPTIC-19
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OPTIC-19
Brief Summary:
This retrospective cohort study aims to characterise outcomes for patients treated on an intensive care unit ICU with COVID-19 in England and Wales one year after discharge from hospital Outcomes will be compared with patients admitted as an emergency to an ICU for other conditions The study will use existing national audit data linked to routine healthcare datasets
Detailed Description:
Across England and Wales over 10000 patients have been treated for severe coronavirus disease 2019 COVID-19 on an intensive care unit Around 60 survived to leave hospital It is unknown how survivors severe COVID-19 infection or the treatment they received on the intensive care unit will affect their long-term health Understanding what happens to these patients can help ensure they receive suitable care from their General Practitioner GP and other National Health Service NHS services after they leave hospital
This study will follow up survivors for 1 year after discharge from hospital The investigators will use data collected by the Intensive Care National Audit and Research Centre ICNARC to identify patients who were treated on an ICU for COVID-19 The investigators will then use NHS data to see whether these patients were readmitted to hospital and why Information from the Office of National Statistics will identify whether patients died By linking different sources of patient data the investigators will estimate the health risks faced by survivors of severe COVID-19 These risks will be compared to those in patients treated on an ICU for other conditions
This study will follow up survivors for 1 year after discharge from hospital The investigators will use data collected by the Intensive Care National Audit and Research Centre ICNARC to identify patients who were treated on an ICU for COVID-19 The investigators will then use NHS data to see whether these patients were readmitted to hospital and why Information from the Office of National Statistics will identify whether patients died By linking different sources of patient data the investigators will estimate the health risks faced by survivors of severe COVID-19 These risks will be compared to those in patients treated on an ICU for other conditions
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 21SC0021 | OTHER | None | None |
| 21CAG0017 | OTHER | Confidentiality Advisory Group | None |